Welcome to Omnimabs!
TEL: 02154156726 Info: info@Omnimabs.com CN

GSK3beta (phospho Ser9) Antibody

Catalog Number:OM280421
OM280421
Discount Price
OM280421-100ul
1~2 Week
100ul
OM280421-50ul
50ul
OM280421-20ul
20ul
1~2 Week
Product Profile
Product Name GSK3beta (phospho Ser9) Antibody
Antibody Type Primary Antibodies
Product description

Participates in the Wnt signaling pathway. Implicated in the hormonal control of several regulatory proteins including glycogen synthase, MYB and the transcription factor JUN. Phosphorylates JUN at sites proximal to its DNA-binding domain, thereby reducing its affinity for DNA. Phosphorylates MUC1 in breast cancer cells, and decreases the interaction of MUC1 with CTNNB1/beta-catenin. Phosphorylates CTNNB1/beta-catenin.1) Fan G, et al. (2003) J Biol Chem. 278 (52): 52432-52436. Barry FA, et al. (2003) FEBS Lett. 553 (1-2): 173-178. Welsh, et al. (1996) Trends Cell Biol. 6: 274-279. Srivastava A K, et al. (1998) Mol Cell Biochem. 182: 135-141.

Immunogen GSK3beta (Phospho-Ser9) antibody was raised against a peptide sequence around phosphorylation site of serine 9 (T-T-S (p) -F-A) derived from Human GSK3β.
Modification p-Ser9
Key Feature
Clonality Polyclonal
Host Species Rabbit
Tested Applications IFIHCWB
Western Blot: 1:500~1:1000, Immunohistochemistry: 1:50~1:100, Immunofluorescence: 1:100~1:200:
Species Reactivity HumanMouseRat
Concentration 1mg/ml
Purification Affinity purified
Target Information
Gene Symbol GSK3B
Alternative Names NFKB3
Factor A
GSK-3 beta
Protein kinase GSK-3-beta
kinase GSK-3 beta
Molecular Weight(MW) 46 kDa
Tissue Specificity This antibody detects endogenous level of GSK3β only when phosphorylated at serine 9.
Database Links
Entrez Gene 2932
Protein Accession NP_001139628.1
Application

Application

Top Image: Immunohistochemical analysis of paraffin-embedded human breast carcinoma tissue using GSK3β (Phospho-Ser9). Bottom Image: Immunofluorescence staining of methanol-fixed HeLa cells showing cytoplasmic staining using GSK3β (Phospho-Ser9).

Application

Western blot analysis of lysed extracts from 293 cells untreated (Lane 1) or treated with serum (lane 2) using GSK3β (Phospho-Ser9).

IHC

Tan IIA increased the expression of p-MEK (A), p-ERK1/2 (B) and p-GSK-3β (C), as assessed by immunohistochemical analysis.

WB

Tan IIA increases the expression of p-MEK (A), p-ERK1/2 (B) and p-GSK-3β (C), as detected by immunoblotting.

WB

(E) Tan IIA increased the expression of p-MEK, p-ERK1/2 and p-GSK-3β, as detected by immunoblotting. G15 could diminish the expression of these proteins induced by Tan IIA. Previous
Application Notes Western Blot: 1:500~1:1000, Immunohistochemistry: 1:50~1:100, Immunofluorescence: 1:100~1:200:
Additional Information
Form Liquid
Storage Instructions Store antibody at -20˚C for up to one year.
Storage Buffer Antibody supplied in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.
validation
question title
question detaiil
Verification code
 

References(1)